Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Withdrawn 1Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Polycystic Ovary Syndrome 9Motor Activity 7Prostatic Neoplasms 3Colorectal Neoplasms 2Urinary Bladder Neoplasms 1Rectal Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, Follicular 1Lupus Erythematosus, Systemic 1Insulin Resistance 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Fatigue 1Diabetes Mellitus, Type 1 1Cardiovascular Diseases 1Cardiotoxicity 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Arthritis, Rheumatoid 1Anxiety Disorders 1

Interventions

Trastuzumab 351Paclitaxel 334Cyclophosphamide 315Docetaxel 292Capecitabine 181Doxorubicin 180Letrozole 165Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 83Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 68Filgrastim 64Albumin-Bound Paclitaxel 64Magnetic Resonance Spectroscopy 56eribulin 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × High-Intensity Interval Training × Clear all
NCT05786014 2025-06-12

The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies

University of Virginia

Phase NA Completed
24 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡